Would also make note of the following (not particularly targeted...

Would also make note of the following (not particularly targeted to you BD, but in response to alot of the previous conjecture re: Bonify) -



The Bonify agreement was via Medcan. I would say that any issues with Bonify are no longer linked to CGB due to Medcan not being acquired. IMO, of course, but there is no mention of Bonify within the latest announcement proceeding with CGB..



Also - Medcan can not currently access Bonify's cannabis plant material due to their Canadian license suspension. The time-frame on that to get sorted (if it does) could be longer than the suspension we are undergoing..


Here we also have Pharmocann JV'ing Medcan - however, they have been specifically referred to in the latest announcement as proceeding with CGB. Clearly that agreement isn't being dropped.



Canntab was involved prior to Medcan, so their agreement would also have no issue surrounding acquisition of Medcan.

I'll leave readers to digest that - however, imo, the whole Bonify issue appears to be no longer applicable to CGB due to omission of any proceeding with Bonify arrangements & Medcan not being acquired.

Without access to Bonify's plant material, I would think that Medcan are highly reliant on MCL's seed bank for cultivation too. They still need MCL as much as MCL needs them.